Key result
Transcatheter device retrieval and reocclusion with Gore Cardioform ASD occluder resolves refractory Gerbode-defect hemolysis.
Why the study?
Significant hemolysis is a recognized complication of transcatheter high-velocity shunt occlusion using some Amplatzer devices.
Case Report (n=1)
The Gore Cardioform Atrial Septal Defect Occluder may serve as an effective alternative for managing severe hemolysis caused by Amplatzer devices in high-velocity shunts.
May offer bailout option for device-related hemolysis; hypothesis-generating case report requiring prospective validation.
Significant hemolysis is a recognized complication of transcatheter high-velocity shunt occlusion using some Amplatzer devices. We describe a case of severe hemolysis following occlusion of an iatrogenic Gerbode defect with an Amplatzer muscular ventricular septal defect occluder successfully managed by transcatheter device removal and reocclusion with a Gore Cardioform Atrial Septal Defect Occluder.
No takes yet. Share an insight, caveat, or question.
Naimi et al. (2022) conducted a case report in Severe hemolysis following transcatheter septal defect closure (n=1). Gore Cardioform Atrial Septal Defect Occluder was evaluated on Management of severe hemolysis. Transcatheter device removal and reocclusion with a Gore Cardioform Atrial Septal Defect Occluder successfully managed severe hemolysis following occlusion of an iatrogenic Gerbode defect.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: